![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1467855
½Å°æ°úÇÐ ½ÃÀå º¸°í¼ : ±¸¼º¿ä¼Ò, ±â¼ú, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)Neuroscience Market Report by Component, Technology, End User, and Region 2024-2032 |
½Å°æ°úÇÐ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2023³â 348¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. IMARC ±×·ìÀº 2024-2032³â 3.3%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸À̸ç 2032³â±îÁö 467¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.
½Å°æ°úÇÐÀº ³ú¿Í ½Å°æ°è¿¡ ´ëÇÑ °úÇÐÀû ¿¬±¸¸¦ ¸»ÇÕ´Ï´Ù. ½Å°æ°úÇÐÀº ¼¼Æ÷»ý¹°ÇÐ, ºÐÀÚ»ý¹°ÇÐ, »ý¸®ÇÐ, ÇØºÎÇÐ, Àΰ£ Çൿ ¹× ÀÎÁö µî ´Ù¸¥ Çй® ºÐ¾ß¿Í ¹ÐÁ¢ÇÏ°Ô ¿¬°èµÈ ´ÙÇÐÁ¦Àû °úÇÐÀÔ´Ï´Ù. ³úÀÇ ÇØºÎÇÐ, ½Å°æÇÐÀû, ½ÅüÀû, ½É¸®Àû ±â´É¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» ´ã°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å°æ°ú ÀÇ»çµéÀÌ ¼ö¸¹Àº ½Å°æ ÁúȯÀÇ Ä¡·á ¹× ¿¹¹æÀ» À§ÇÑ ¾à¹°°ú Àü·«À» °³¹ßÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ´Ù¾çÇÑ ¿äÀÎÀ» ÀÌÇØÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ÇöÀç ¿¬±¸ÀÚµé°ú ½Å°æ°úÇÐÀÚµéÀº Áúº´ °æ·Î¸¦ ±Ô¸íÇϰí, Áúº´À» Á¶±â¿¡ Áø´ÜÇϰí, ÀÎÁö °úÁ¤À» ÀÌÇØÇÏ´Â µ¥ °ü¿©ÇÏ´Â ½Å°æ ³×Æ®¿öÅ©¸¦ ÆÄ¾ÇÇϱâ À§ÇØ Ã·´Ü ¿µ»ó ±â¼úÀ» »ç¿ëÇϰí ÀÖ½À´Ï´Ù.
ÆÄŲ½¼º´, ¾ËÃ÷ÇÏÀ̸Ӻ´, Á¤½ÅºÐ¿Áõ, ±âŸ ³ú °ü·Ã Áúȯ µî ´Ù¾çÇÑ ½Å°æ ÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö°¡ Áõ°¡ÇÏ¸é¼ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ½Å°æ ¿µ»ó Áø´Ü Àåºñ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ÁøÇà ÁßÀÎ ³ú ¸ÅÇÎ ¿¬±¸ ¹× Á¶»ç ÇÁ·ÎÁ§Æ®µµ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¢±¹ Á¤ºÎ´Â ½Å°æ Áúȯ°ú Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀνÄÀ» Á¦°íÇϱâ À§ÇØ Àû±ØÀûÀÎ ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² ÀϺΠ½Å°æ ÁúȯÀÇ Áø´Ü¿¡ Çö¹Ì°æ, ±¤À¯ÀüÇÐ, ÀÚ±â°ø¸í¿µ»ó(MRI), Àü±â»ý¸®ÇÐ ÀåºñÀÇ »ç¿ë Áõ°¡´Â ½ÃÀå ¼ºÀåÀÇ Ã˸ÅÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷µéÀº Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇÏ°í °æÀï ¿ìÀ§¸¦ È®º¸Çϱâ À§ÇØ È¿À²¼º°ú ȯÀÚ ¼øÀÀµµ¸¦ Çâ»ó½ÃŰ´Â Çõ½ÅÀûÀÎ ÀÇ·á±â±â¸¦ °³¹ßÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, MRI¿Í ½Å°æ Çö¹Ì°æÀÌ ´Ù¸¥ ¿µ»óÁø´Ü Àåºñ¿Í °áÇÕÇÏ¿© ±âÁ¸ÀÇ ´ÜÀÏ ¿µ»óÁø´Ü Àåºñº¸´Ù ¿ì¼öÇÏ´Ù´Â µî ÷´Ü ½Å°æ°úÇÐ ÀåºñÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¹Û¿¡µµ ¿¬±¸°³¹ß(R&D) Ȱµ¿¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±ÝÀÇ ±ÞÁõ, ½Å°æ°úÇÐ ¹× ½Å°æ±â¼ú ºÎ¹®ÀÇ ¹ßÀü, ÀÇ·áºñ Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó °³¼± µîµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
The global neuroscience market size reached US$ 34.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 46.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.3% during 2024-2032.
Neuroscience refers to the scientific study of the brain and nervous system. It is an interdisciplinary science that works closely with other disciplines, including cellular and molecular biology, physiology, anatomy, and human behavior and cognition. It provides valuable insights into the anatomy of the brain and neurological, physical, and psychological functioning. It also assists neurologists in understanding various factors that can aid in the development of medications and strategies to treat and prevent numerous neurological disorders. Nowadays, researchers and neuroscientists are increasingly employing advanced imaging techniques for identifying neural networks involved in understanding disease pathways, early disease diagnosis, and cognitive processes.
The increasing number of deaths due to various neurological disorders, such as Parkinson's disease, Alzheimer's, schizophrenia, and other brain-related conditions, represents the primary factor driving the market growth. Besides this, the escalating demand for neuroimaging devices and the ongoing brain mapping research and investigation projects are other major growth-inducing factors. Additionally, the governments of various nations are taking favorable initiatives to spread awareness about neurological diseases and the available treatment options. Along with this, the rising usage of microscopy, optogenetics, magnetic resonance imaging (MRI), and electrophysiology instruments in the diagnosis of several neurological disorders is catalyzing the market growth. Furthermore, the leading players are developing innovative medical devices that offer enhanced efficiency and patient compliance to expand their product portfolio and gain a competitive edge. Moreover, the growing awareness regarding the benefits of advanced neuroscience devices, such as the combination of other imaging devices along with the MRI and neuro microscopes over conventional standalone imaging devices, is propelling the market growth. Other factors, including the surging government funding for research and development (R&D) activities, advancements in the field of neuroscience and neuro-technology, increasing healthcare expenditure, rising geriatric population, and improving healthcare infrastructure, are also providing a positive thrust to the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global neuroscience market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on component, technology and end user.
Instruments and Consumables
Software and Services
Brain Imaging
Neuro-Microscopy
Electrophysiology
Neuroproteomic Analysis
Animal Behaviour Analysis
Others
Hospitals
Diagnostic Laboratories
Research and Academic Institutes
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alpha Omega Engineering, Biobserve GmbH, Blackrock Neurotech, Doric Lenses Inc., General Electric Company, Kernel, Laserglow Technologies, Mightex Systems, NeuroNexus Technologies Inc., Noldus Information Technology B.V., Plexon Inc., Prizmatix Ltd. and Siemens AG.